New Insights into the Biological and Clinical Significance of Fecal Calprotectin in Inflammatory Bowel Disease

REFERENCES

• Fagerhol M.K., Dale I., Andersson T. Release and quantitation of a leukocyte derived protein (L1). Scand. J. Haematol. 1980, 24: 393–398, [CSA]
   Google Scholar
• Hessian P.A., Edgeworth J., Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J. Leukoc. Biol. 1993; 53(2)197–204, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bhardwaj R.S., Zotz C., Zwadlo-Klarwasser G., Roth J., Goebeler M., et al. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur. J. Immunol. 1992; 22(7)1891–1897, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P., Dale I., Fagerhol M.K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am. J. Clin. Pathol. 1987; 87(6)700–770, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Doussiere J., Bouzidi F., Vignais P.V. The S100A8/A9 protein as a partner for the cytosolic factors of NADPH oxidase activation in neutrophils. Eur. J. Biochem. 2002; 269(13)3246–3255, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Helbert M.J., Dauwe S.E., De Broe M.E. Flow cytometric immunodissection of the human distal tubule and cortical collecting duct system. Kidney Int. 2001; 59(2)554–564, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Roth J., Burwinkel F., van den Bos C., Goebeler M., Vollmer E. Sorg, C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993; 82(6)1875–1883, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Striz I., Trebichavsky I. Calprotectin—a pleiotropic molecule in acute and chronic inflammation. Physiol. Res. 2004; 53(3)245–253, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Dale I. Plasma levels of the calcium-binding L1 leukocyte protein: standardization of blood collection and evaluation of reference intervals in healthy controls. Scand. J. Clin. Lab. Invest. 1990; 50(8)837–841, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Holt J., Fagerhol M.K., Dale I. Quantitation of a leukocyte protein (L1) in urine. Acta Paediatr. Scand. 1983; 72(4)615–616, [INFOTRIEVE], [CSA]
   Google Scholar
• Boussac M., Garin J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 2000; 21(3)665–672, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Rammes S., Kewitz G., Versmold H., Niggemann B., Rammes A. Myeloid-related protein (MRP)8 and MRP14, calcium binding proteins of the S100 family, are secreted by activate monocytes via a novel tubulin-dependent pathway. Pediatr. Allergy Immunol. 1997; 8(3)153–155, [INFOTRIEVE], [CSA]
   Google Scholar
• Voganatsi A., Panyutich A., Miyasaki K.T., Murthy R.K. Mechanism of extracellular release of human neutrophil calprotectin complex. J. Leukoc. Biol. 2001; 70(1)130–134, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Clohessy P.A., Golden B.E. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand. J. Immunol. 1995; 42(5)551–655, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Loomans H.J., Hahn B.L., Li Q.Q., Phadnis S.H., Sohnle P.G. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J. Infect. Dis. 1998; 177(3)812–814, [INFOTRIEVE], [CSA]
   Google Scholar
• Steinbakk M., Naess-Andresen C.F., Lingaas E., Dale I., Brandtzaeg P., Fagerhol M.K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990; 336(8718)763–765, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lusitani D., Malawista S.E., Montgomery R.R. Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi. Infect. Immun. 2003; 71(8)4711–4716, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Murao S., Collart F.R., Huberman E. A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases. J Biol Chem. 1989; 264(14)8356–8360, [INFOTRIEVE], [CSA]
   Google Scholar
• Yui S., Mikami M, Yamazaki M. Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells. J. Leukoc. Biol. 1995; 58(6)650–658, [INFOTRIEVE], [CSA]
   Google Scholar
• Mahnke K., Bhardwaj R., Sorg C. Heterodimers of the calcium-binding proteins MRP8 and MRP14 are expressed on the surface of human monocytes upon adherence to fibronectin and collagen. Relation to TNF-alpha, IL-6, and superoxide production. J. Leukoc. Biol. 1995; 57(1)63–71, [INFOTRIEVE], [CSA]
   Google Scholar
• Kerkhoff C., Klempt M., Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim. Biophys. Acta 1998; 1448(2)200–211, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hofmann M.A., Drury S., Hudson B.I., Gleason M.R., Qu W. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002; 3(3)123–135, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Srikrishna G., Panneerselvam K., Westphal V., Abraham V., Varki A., Freeze H.H. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J. Immunol. 2001; 166(7)4678–4688, [INFOTRIEVE], [CSA]
   Google Scholar
• Freemont P., Hogg N., Edgeworth J. Sequence identity. Nature 1989; 339(6225)516, [CSA]
   Google Scholar
• Newton R.A., Hogg N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J. Immunol. 1998; 160(3)1427–1435, [INFOTRIEVE], [CSA]
   Google Scholar
• Sander J., Fagerhol M.K., Bakken J.S., Dale I. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand. J. Clin. Lab. Invest. 1984; 44(4)357–62, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Pechkovsky D.V., Zalutskaya O.M., Ivanov G.I., Misuno N.I. Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. FEMS Immunol. Med. Microbiol. 2000; 29(1)27–33, [CSA]
   Google Scholar
• Striz I., Pokorna-Sochurkova H., Zheng L., Jaresova M., Guzman J., Costabel U. Calprotectin expression and mononuclear phagocyte subpopulations in peripheral blood and bronchoalveolar lavage. Sarcoidosis Vasc. Diffuse Lung. Dis. 2001; 18(1)57–63, [CSA]
   Google Scholar
• Madland T.M., Hordvik M., Haga H.J., Jonsson R., Brun J.G. Leukocyte protein calprotectin and outcome in rheumatoid arthritis. A longitudinal study. Scand. J. Rheumatol. 2002; 31(6)351–354, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Striz I., Wang Y.M., Svarcova I., Trnka L., Sorg C., Costabel U. The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage. Eur. Respir. J. 1993; 6(9)1287–1294, [INFOTRIEVE], [CSA]
   Google Scholar
• Burkhardt K., Bosnecker A., Hillebrand G., Hofmann G.O., Schneeberger H., et al. MRP8/14-positive macrophages as early acute cellular rejection markers, and soluble MRP8/14 and increased expression of adhesion molecules following renal transplantation. Transplant Proc. 1995; 27(1)890–891, [INFOTRIEVE], [CSA]
   Google Scholar
• Gebhardt C., Breitenbach U., Tuckermann J.P., Dittrich B.T., Richter K.H., Angel P. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene 2002; 21(27)4266–4276, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Youssef P., Roth J., Frosch M., Costello P., Fitzgerald O., et al. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J. Rheumatol. 1999; 26(12)2523–2528, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Saverymuttu S.H., Peters A.M., Lavender J.P., Hodgson H.J., Chadwick V.S. 111 Indium autologous leucocytes in inflammatory bowel disease. Gut 1983; 24(4)293–299, [INFOTRIEVE], [CSA]
   Google Scholar
• Roseth A.G., Schmidt P.N., Fagerhol M.K. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 1999; 34(1)50–54, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tibble J.A., Sigthorsson G., Bridger S., Fagerhol M.K., Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000; 119(1)15–22, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tibble J.A., Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J. Gastroenterol. 2001; 7(4)460–465, [INFOTRIEVE], [CSA]
   Google Scholar
• Laake K.O., Line P.D., Grzyb K., Aamodt G., Aabakken L. Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA). Scand. J. Gastroenterol. 2004; 39(12)1228–1235, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gaya D.R., Lyon T.D., Duncan A., Neilly J.B., Han S., et al. Faecal calprotectin in the assessment of Crohn's disease activity. Q. J. Med. 2005; 98(6)435–441, [CSA]
   Google Scholar
• Wright J.P., Young G.O., Tigler-Wybrandi N. Predictors of acute relapse of Crohn's disease. A laboratory and clinical study. Dig Dis Sci. 1987; 32(2)164–170, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Malchow H., Ewe K., Brandes J.W., Goebell H., Ehms H., et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86(2)249–266, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Costa F., Mumolo M.G., Bellini M., Romano M.R., Ceccarelli L., et al. Role of faecal calprotectin as a non-invasive marker of intestinal inflammation. Dig. Liver Dis. 2003; 35: 642–647, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Tibble J., Teahon K., Thjodleifsson B., Roseth A., Sigthorsson G., et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47: 506–513, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bjerke K., Halstensen T.S., Jahnsen F., Pulford K., Brandtzaeg P. Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 1993; 34(10)1357–1363, [INFOTRIEVE], [CSA]
   Google Scholar
• Pardi D.S., Sandborn W.J. Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?. Gut 2005; 54(3)321–322, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Roseth A.G., Aadland E., Jahnsen J., Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997; 58(2)176–180, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Costa F., Mumolo M.G., Ceccarelli L., Bellini M., Romano M.R. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 2005; 54(3)364–368, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hanaway P., Roseth A. Inflammatory biomarkers predict relapse in IBD. Gut 2005; 54(9)1346–1347, [Letter].[INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Lemann M., Mary J.Y. Calprotectin and IBD. Gut 2005; 54(9)1349–1350, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Caradonna L., Amati L., Lella P., Jirillo E., Caccavo D. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am. J. Gastroenterol. 2000; 95(6)1495–1502, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Amati L., Caradonna L., Leandro G., Magrone T., Minenna M., et al. Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effects. Curr. Pharm. Des. 2003; 9(24)1937–1945, [INFOTRIEVE], [CSA]
   Google Scholar
• Amati L., Caradonna L., Jirillo E., Caccavo D. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications. Ital. J. Gastroenterol. Hepatol. 1999; 31(4)313–325, [INFOTRIEVE], [CSA]
   Google Scholar
• Hanai H., Takeuchi K., Iida T., Kashiwagi N., Saniabadi A.R., et al. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis. Dig. Dis. Sci. 2004; 49(9)1438–1443, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Nikolaus S., Bauditz J., Gionchetti P., Witt C., Lochs H., Schreiber S. Increase secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1998; 42(4)470–476, [INFOTRIEVE], [CSA]
   Google Scholar
• Amati L., Passeri M.E., Mastronardi M.L., Jirillo E. Anti-tumor necrosis factor-alpha monoclonal antibody (Infliximab) therapy in patients with inflammatory bowel disease: applications and side effects. Drug Design Rev. (online) 2004; 1(2)111–1117, [CSA], [CROSSREF]
   Google Scholar
• Brannigan A.E., O'Connell P.R., Hurley H., O'Neill A., Brady H.R., et al. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 2000; 13(5)361–366, [INFOTRIEVE], [CSA]
   Google Scholar
• Caradonna L., Amati L., Magrone T., Pellegrino N.M., Jirillo E., Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin. Res. 2000; 6(3)205–214, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Ransohoff R.M. Selective leukocyte chemoattractants emerge from the primeval sup(ernatants). J. Immunol. 2005; 175(9)5567–5568, [INFOTRIEVE], [CSA]
   Google Scholar
• Calkins B.M. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig. Dis. Sci. 1989; 34(12)1841–1854, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schimitz-Moorman P., Becker H. Histological studies on the formal pathogenesis of the epithelial cell granuloma in Crohn's disease. A.S. Pena, I.T. Weterman, C.C. Both, W. Strober. Martinus Nijhoff, The Hague 1981; 76–79
   Google Scholar
• Greenstein A.J., Lachman P., Sachar D.B., Springhorn J., Heimann T., et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988; 29(5)588–592, [INFOTRIEVE], [CSA]
   Google Scholar
• Langhorst J., Elsenbruch S., Mueller T., Rueffer A., Spahn G., et al. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm. Bowel Dis. 2005; 11(12)1085–10891, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar